Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | and similar dates through November 2027

Funding Amounts: Up to $499,000 direct costs per year, for up to 5 years (R01 mechanism; no clinical trials allowed)

Summary: Supports academic-industrial partnerships to translate technologies for diagnosis and treatment, with a focus on cancer and related diseases; clinical trials are not permitted.

Key Information: Requires at least one academic and one industrial partner; open to U.S. and non-U.S. organizations; projects must emphasize translation, not basic research or commercial production.